AGING AND THE HUMAN ANTIBODY RESPONSE TO C. DIFFICILE

衰老和人类抗体对艰难梭菌的反应

• 批准号: 6612738
• 负责人: LORRAINE KYNE
• 金额: $ 13.57万
• 依托单位: BETH ISRAEL DEACONESS MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2000
• 资助国家: 美国
• 起止时间: 2000-08-15 至 2005-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6612738
• 关键词: Clostridium difficile; aging; antibiotics; bactericidal immunity; biomarker; clinical research; clostridial infection; curriculum; diarrhea; disease /disorder proneness /risk; geriatrics; human old age (65+); human subject; medical education; microorganism disease chemotherapy; training

A research program will be undertaken by the applicant, Lorraine Kyne, MD, MPH in the Division of Gerontology at the Beth Israel Deaconess Medical Center (BIDMC). The award will provide five years of mentored training and research enabling her to develop her potential to become an independent clinical investigator focusing on patient-oriented research. Dr Jeanne Y. Wei, Chief of Gerontology at BIDMC, Director of the Division on Aging at Harvard Medical School and Dr. Ciaran P. Kelly, Associate Physician in the Division of Gastroenterology, BIDMC, will serve as mentors. The research component will focus on an important iatrogenic, nosocomial condition which affects predominantly older patients: Clostridium difficile-associated disease (CDAD). As the conventional antibiotic therapy of this condition is associated with a high relapse rate and the emergence of antimicrobial resistance, the long term goals of this project are to develop immunobiological products to prevent or ameliorate disease due to C. difficile and to test their efficacy in intervention studies in 'high risk' older persons. The specific aims of this project are; 1) to identify surrogate markers of immune protection against severe, prolonged or recurrent C. difficile diarrhea for use in future C. difficile active or passive immunization trials; 2) to explore the inter- relationship between the immune response to C. difficile, disease due to C. difficile and aging; and 3) to determine the clinical correlates of CDAD, in order to develop a clinical prediction rule which may be used to identify high risk individuals who may benefit from immunization or other preventative strategies. In addition to this project and scheduled meetings with Drs. Wei and Kelly, this award will include a formal research curriculum, including 1) Research ethics, 2) Clinical epidemiology, 3) Statistical analysis, 4) Clinical trials, 5) Aging research and 5) Laboratory techniques. The very substantial research, educational, and clinical resources of the Harvard Division on Aging and the BIDMC Gerontology and Gastroenterology Divisions will be committed to the applicant to ensure successful attainment of the goals of this award.

申请人Lorraine Kyne，医学博士，公共卫生硕士，在贝斯以色列女执事医疗中心（BIDMC）的老年学部门进行一项研究计划。该奖项将提供五年的指导培训和研究，使她能够发展自己的潜力，成为一名独立的临床研究者，专注于以患者为导向的研究。哈佛医学院老年学部主任、老年学主任Jeanne Y. Wei博士和消化内科副医师Ciaran P. Kelly博士将担任导师。研究部分将侧重于主要影响老年患者的重要医源性医院疾病：艰难梭菌相关疾病（CDAD）。由于这种疾病的传统抗生素治疗与高复发率和抗菌素耐药性的出现有关，该项目的长期目标是开发免疫生物学产品，以预防或改善艰难梭菌引起的疾病，并在“高风险”老年人的干预研究中测试其疗效。该项目的具体目标是：1)为今后的艰难梭菌主动或被动免疫试验寻找针对严重、长期或复发性艰难梭菌腹泻的免疫保护替代标志物；2)探讨艰难梭菌免疫应答、艰难梭菌所致疾病与衰老的相互关系；3)确定CDAD的临床相关性，以便制定临床预测规则，用于识别可能受益于免疫或其他预防策略的高危人群。除了这个项目和与博士的预定会议。该奖项将包括一个正式的研究课程，包括1)研究伦理，2)临床流行病学，3)统计分析，4)临床试验，5)老龄化研究和5)实验室技术。哈佛大学老龄学部和BIDMC老年学和胃肠病学学部的大量研究、教育和临床资源将致力于确保申请人成功实现本奖项的目标。